RIPK1 inhibition attenuates experimental autoimmune arthritis via suppression of osteoclastogenesis
Abstract Background Rheumatoid arthritis (RA) is a chronic and systemic inflammatory disease characterized by upregulation of inflammatory cell death and osteoclastogenesis. Necrostatin (NST)-1s is a chemical inhibitor of receptor-interacting serine/threonine-protein kinase (RIPK)1, which plays a ro...
Main Authors: | Jooyeon Jhun, Seung Hoon Lee, Se-Young Kim, Jaeyoon Ryu, Ji Ye Kwon, Hyun Sik Na, KyoungAh Jung, Su-Jin Moon, Mi-La Cho, Jun-Ki Min |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-03-01
|
Series: | Journal of Translational Medicine |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12967-019-1809-3 |
Similar Items
-
Electrochemotherapy Causes Caspase-Independent Necrotic-Like Death in Pancreatic Cancer Cells
by: Philana Fernandes, et al.
Published: (2019-08-01) -
Promotion of osteoclastogenesis by IL-26 in rheumatoid arthritis
by: Kyung-Ann Lee, et al.
Published: (2019-12-01) -
TGF-β in the Secretome of Irradiated Peripheral Blood Mononuclear Cells Supports In Vitro Osteoclastogenesis
by: Layla Panahipour, et al.
Published: (2020-11-01) -
Necrostatin-1 Prevents Ferroptosis in a RIPK1- and IDO-Independent Manner in Hepatocellular Carcinoma
by: Hanna Yuk, et al.
Published: (2021-08-01) -
Direct comparison of cardioprotective effects of necroptosis inhibitors against global ischemia-reperfusion in the isolated rat heart
by: Yu. V. Dmitriev, et al.
Published: (2018-01-01)